[Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations].
D000328:Adult; D002994:Clofibrate / Q000627:therapeutic use*; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009132:Muscles / Q000201:enzymology*; D009135:Muscular Diseases / Q000139:chemically induced*; D009404:Nephrotic Syndrome / Q000150:complications; D010146:Pain; D000637:Transaminases / Q000097:blood
D000637:Transaminases; D005634:Fructose-Bisphosphate Aldolase; D002994:Clofibrate
Traitement de l'hyperlipémie par le clofibrate dans un cas de syndrome néphrotique: altérations musculaires et enzymatiques secondaires.